German Data Protection Commissioner Urges Clearer Information and Granular Controls for Electronic P
Germany's Federal Data Protection Commissioner (BfDI) has issued recommendations urging the Federal Government to improve public information and give insured persons finely differentiated control over who can view their electronic patient record (ePA) data. From the end of October 2026, pseudonymized medication list data can be extracted from the ePA for research unless the insured person objects. Compliance teams at health-sector organizations and research partners should treat this as a signal of regulatory expectations for consent, transparency, and secondary use of health data.


